[1]EuropeanJournalofOrganicChemistry,2008,#8,p.1458-1463
[1]OrganicLetters,2013,vol.15,#6,p.1346-1349
[1]OrganicLetters,2013,vol.15,p.1346-1349
[1]CurrentPatentAssignee:CORTEVAINC-WO2019/84353,2019,A1Locationinpatent:Paragraph00184
458532-96-2
847664-64-6
668971-16-2 | 5-(2-Methoxyphenyl)isoxazole-3-carboxylic acid | AA006Q7E | MFCD07377106
916766-83-1 | 3-[4-(Chloromethyl)phenyl]-1-methyl-1h-pyrazole | AA006R75 | MFCD09702351
98349-23-6 | 2,4,5-Trifluorobenzamide | AA006SHE | MFCD00082478
915920-87-5 | N-Ethyl-2-(p-tolyloxy)ethanamine | AA006TC7 | MFCD08691946
25563-04-6 | 2-(2-(4-Chlorophenoxy)phenyl)acetic acid | AA006TY1 | MFCD15528958
142355-81-5 | 1-Boc-4-(4-bromo-butyl)-piperidine | AA006UL9 | MFCD07369864
51572-91-9 | 1-[(Ammoniooxy)methyl]-2-bromobenzene chloride | AA006V63 | MFCD01114573
501653-22-1 | 5-(CHLOROMETHYL)-3-(2-FURYL)-1,2,4-OXADIAZOLE | AA006VRD | MFCD07636853
51379-07-8 | Bis(4-methylumbelliferyl)phosphate | AA006WDG | MFCD00076128
226700-81-8 | Fosamprenavir calcium | AA006WYL | MFCD08141843